Home / AVCTF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AVCTF make money? Does AVCTF have pricing power? What's the Earnings Whisper? Will AVCTF profit more as the business scales? What is AVCTF's management track record? Is AVCTF's current price justified?

Avacta Group Plc

$0.97 +$0.19 (+24.69%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

$0.95

Day Range

$0.95$0.97

Year Range

$0.74$1.23

Market Cap

454.35M

AVG Volume

12.03K

Trailing/Forward PE

-8.46/-

PEG ratio

0.56

Dividend Yield

Next Earnings Date

2026-10-05

Primary Exchange

Other OTC

Revenue (GBP)

AVCTF Revenue (GBP) by quarter
Period	Revenue (GBP)
25 Q4	56.99K
25 Q2	56K
24 Q2	11.26M
23 Q4	11.36M
23 Q2	11.89M
22 Q4	4.14M
22 Q2	5.52M
21 Q4	620K
21 Q2	2.32M
20 Q4	1.83M

Net Income (GBP)

AVCTF Net Income (GBP) by quarter
Period	Net Income (GBP)
25 Q4	-21.35M
25 Q2	-17.73M
24 Q2	-12.47M
23 Q4	-13.41M
23 Q2	-11.53M
22 Q4	-30.56M
22 Q2	-8.94M
21 Q4	-16.12M
21 Q2	-10.2M
20 Q4	-11.9M

Operating Income (GBP)

AVCTF Operating Income (GBP) by quarter
Period	Operating Income (GBP)
25 Q4	-17.14M
25 Q2	-17.97M
24 Q2	-17.25M
23 Q4	-15.54M
23 Q2	-11.17M
22 Q4	-16.53M
22 Q2	-9M
21 Q4	-17.75M
21 Q2	-11.34M
20 Q4	-11.23M

EBITDA (GBP)

AVCTF EBITDA (GBP) by quarter
Period	EBITDA (GBP)
25 Q4	-16.6M
25 Q2	-12.35M
24 Q2	-13.36M
23 Q4	-13.59M
23 Q2	-9.46M
22 Q4	-14.85M
22 Q2	-7.68M
21 Q4	-16.45M
21 Q2	-10.26M
20 Q4	-10.27M

Cash Flows (GBP)

AVCTF Cash Flows (GBP) by quarter
Period	Cash Flows (GBP)
25 Q4	-11.25M
25 Q2	-18.6M
24 Q4	0
24 Q2	-13.02M
23 Q4	-7.59M
23 Q2	-8.5M
22 Q4	-11.06M
22 Q2	-5.97M
21 Q4	-10.77M
21 Q2	-11.05M

EPS (GBP)

AVCTF EPS (GBP) by quarter
Period	EPS (GBP)
25 Q4	-0.05
25 Q2	-0.04
24 Q2	-0.04
23 Q4	-0.05
23 Q2	-0.04
22 Q4	-0.12
22 Q2	-0.04
21 Q4	-0.06
21 Q2	-0.04
20 Q4	-0.05

Expenses (GBP)

AVCTF Expenses (GBP) by quarter
Period	Expenses (GBP)
24 Q4	0
25 Q4	16.67M
25 Q2	17.1M
24 Q2	19.08M
23 Q4	18.85M
23 Q2	16.66M
22 Q4	16.94M
22 Q2	13.41M
21 Q4	15.33M
21 Q2	12.57M
20 Q4	11.22M

Cash & Debt (GBP)

AVCTF Cash & Debt (GBP) by quarter
Period	Cash & Debt (GBP)
25 Q4	16.85M
25 Q2	12.64M
24 Q4	12.87M
24 Q2	32.53M
23 Q4	16.63M
23 Q2	25.97M
22 Q4	41.78M
22 Q2	17.02M
21 Q4	26.19M
21 Q2	36.97M

Debt ratios

AVCTF Debt ratios by quarter
Period	Debt ratios
24 Q2	0.2
23 Q4	-0.14
23 Q2	0.07
22 Q4	0.36
22 Q2	0.27
21 Q4	0.56
21 Q2	1.06
20 Q4	1.69
20 Q2	2.48
19 Q4	0.43

Margins

AVCTF Margins by quarter
Period	Margins
25 Q4	-849.13%
25 Q2	-1671.87%
24 Q2	44.59%
23 Q4	22.35%
23 Q2	42.35%
22 Q4	6.79%
22 Q2	71.6%
21 Q4	-472.9%
21 Q2	18.53%
20 Q4	-0.38%

Return on Capital

AVCTF Return on Capital by quarter
Period	Return on Capital
25 Q4	-862.4%
25 Q2	-12311.11%
24 Q2	-25.9%
23 Q4	-61.52%
23 Q2	-50.72%
22 Q4	-165.73%
22 Q2	-24.84%
21 Q4	-39.1%
21 Q2	-19.08%
20 Q4	-19.21%

Shares Outstanding

AVCTF Shares Outstanding by quarter
Period	Shares Outstanding
25 Q4	436.67M
25 Q2	381.24M
24 Q2	326.9M
23 Q4	275.79M
23 Q2	269.16M
22 Q4	259.64M
22 Q2	251.18M
21 Q4	249.74M
21 Q2	249.13M
20 Q4	248.4M

Book Value Per Share (GBP)

AVCTF Book Value Per Share (GBP) by quarter
Period	Book Value Per Share (GBP)
25 Q4	0.01
25 Q2	0
24 Q2	0.15
23 Q4	0.08
23 Q2	0.08
22 Q4	0.07
22 Q2	0.14
21 Q4	0.17
21 Q2	0.21
20 Q4	0.25

Total Assets (GBP)

AVCTF Total Assets (GBP) by quarter
Period	Total Assets (GBP)
25 Q4	29.41M
25 Q2	29.24M
24 Q4	48.27M
24 Q2	89.29M
23 Q4	73.19M
23 Q2	87.75M
22 Q4	92.65M
22 Q2	45.46M
21 Q4	47M
21 Q2	60.31M

Free Cash Flow Yield

AVCTF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-13.7%
Sep 26	-13.91%
Sep 26	-14.19%
Aug 26	-14.21%
Aug 26	-14.43%
Aug 26	-14.77%
Aug 26	-14.09%
Jul 26	-14.6%
Jul 26	-14.43%
Jul 26	-13.21%
Jul 26	-13.16%
Jul 26	-13.11%
Jun 26	-12.96%
Jun 26	-12.97%
Jun 26	-13.16%
Jun 26	-13.1%
May 26	-13.21%
May 26	-12.93%
May 26	-10.64%
May 26	-13.78%
May 26	-13.72%
Apr 26	-14.88%
Apr 26	-14.86%
Apr 26	-14.8%
Apr 26	-14.97%
Mar 26	-15.73%
Mar 26	-16.51%
Mar 26	-13.87%
Mar 26	-15.16%
Feb 26	-14.91%
Feb 26	-17.33%
Feb 26	-17.56%
Feb 26	-16.28%
Jan 26	-19.06%
Jan 26	-19.01%
Jan 26	-18.51%
Jan 26	-17.72%
Jan 26	-17.79%
Dec 25	-17.04%
Dec 25	-12.4%
Dec 25	-12.39%
Dec 25	-12.35%
Nov 25	-14.06%
Nov 25	-12.83%
Nov 25	-12.91%
Nov 25	-12.9%
Oct 25	-12.84%
Oct 25	-13.04%
Oct 25	-13.15%
Oct 25	-13.08%
Oct 25	-14.73%
Mar 25	-30.55%
Mar 25	-30.79%
Mar 25	-30.84%
Mar 25	-30.81%
Feb 25	-29.98%
Feb 25	-24.9%
Feb 25	-24.82%
Feb 25	-24.46%
Jan 25	-23.48%
Jan 25	-23.65%
Jan 25	-21.58%
Jan 25	-21.65%
Jan 25	-27.02%
Dec 24	-26.64%
Dec 24	-27.63%
Dec 24	-27.59%
Dec 24	-27.86%
Nov 24	-23.99%
Nov 24	-23.61%
Nov 24	-23.77%
Nov 24	-24.34%
Nov 24	-19.48%
Oct 24	-19.54%
Oct 24	-19.09%
Oct 24	-22.97%
Oct 24	-23.08%
Sep 24	-23.03%
Sep 24	-16.41%
Sep 24	-16.17%
Sep 24	-16.17%
Aug 24	-17.05%
Aug 24	-17.16%
Aug 24	-20.34%
Aug 24	-20.05%
Aug 24	-16.94%
Jul 24	-17.03%
Jul 24	-17.08%
Jul 24	-17.18%
Jul 24	-18.59%
Jun 24	-27.83%
Jun 24	-31.92%
May 24	-30.05%
May 24	-25.29%
Apr 24	-25.47%
Apr 24	-25.71%
Mar 24	-26.01%
Mar 24	-25.61%
Feb 24	-10.55%
Jan 24	-10.61%

Price to Sales

AVCTF Price to Sales by quarter
Period	Price to Sales
Mar 25	3.4
Mar 25	3.38
Mar 25	3.37
Mar 25	3.37
Feb 25	3.47
Feb 25	4.17
Feb 25	4.19
Feb 25	4.25
Jan 25	4.43
Jan 25	4.4
Jan 25	4.82
Jan 25	4.8
Jan 25	3.85
Dec 24	3.9
Dec 24	3.76
Dec 24	3.77
Dec 24	3.73
Nov 24	4.33
Nov 24	4.4
Nov 24	4.37
Nov 24	4.27
Nov 24	5.34
Oct 24	5.32
Oct 24	5.45
Oct 24	4.53
Oct 24	4.5
Sep 24	4.37
Sep 24	6.13
Sep 24	6.23
Sep 24	6.22
Aug 24	5.91
Aug 24	5.86
Aug 24	4.95
Aug 24	5.02
Aug 24	5.94
Jul 24	5.91
Jul 24	5.89
Jul 24	5.86
Jul 24	5.42
Jun 24	3.62
Jun 24	3.15
May 24	3.35
May 24	3.98
Apr 24	3.95
Apr 24	3.92
Mar 24	6.3
Mar 24	6.4
Feb 24	15.53
Jan 24	15.43
Jan 24	15.47
Dec 23	15.45
Dec 23	15.49
Dec 23	15.52
Dec 23	16.74
Dec 23	15.96
Nov 23	15.22
Nov 23	15.79
Nov 23	19.77
Nov 23	19.54
Oct 23	19.94
Oct 23	19.67
Oct 23	19.71
Oct 23	15.88
Sep 23	18.92
Sep 23	26.45
Sep 23	29.13
Sep 23	28.94
Sep 23	28.66
Aug 23	28.68
Aug 23	28.34
Aug 23	24.35
Jul 23	24.06
Jun 23	24.32
May 23	25.04
May 23	20.7
May 23	20.7
May 23	20.4
Apr 23	20.51
Apr 23	20.71
Apr 23	20.76
Apr 23	20.71
Mar 23	20.89
Mar 23	40.93
Mar 23	41.12
Mar 23	41.61
Mar 23	41.57
Feb 23	41.93
Feb 23	41.58
Feb 23	41.52
Feb 23	40.52
Jan 23	33.69
Jan 23	45.1
Jan 23	31.54
Jan 23	31.91
Dec 22	31.9
Dec 22	32.03
Dec 22	25.54
Dec 22	25.3
Dec 22	25.23
Nov 22	15.56

Price to Book

AVCTF Price to Book by quarter
Period	Price to Book
Sep 26	126.45
Sep 26	124.53
Sep 26	122.05
Aug 26	121.9
Aug 26	119.99
Aug 26	117.26
Aug 26	122.88
Jul 26	118.6
Jul 26	120.04
Jul 26	131.1
Jul 26	131.64
Jul 26	132.13
Jun 26	133.64
Jun 26	133.52
Jun 26	131.58
Jun 26	132.22
May 26	131.08
May 26	133.94
May 26	162.84
May 26	125.71
May 26	126.25
Apr 26	116.42
Apr 26	116.56
Apr 26	117.03
Apr 26	115.66
Mar 26	1730.98
Mar 26	1649.48
Mar 26	1964.03
Mar 26	1796.24
Feb 26	1826.09
Feb 26	1571.08
Feb 26	1551.03
Feb 26	1672.43
Jan 26	1428.51
Jan 26	1432.73
Jan 26	1471.27
Jan 26	1536.55
Jan 26	1530.36
Dec 25	1598.58
Dec 25	2197.04
Dec 25	2197.6
Dec 25	2204.39
Nov 25	1936.32
Nov 25	2122.26
Nov 25	2110.14
Nov 25	2111.61
Oct 25	2120.68
Oct 25	2088.4
Oct 25	2070.75
Oct 25	2081.37
Oct 25	1848.26
Mar 25	2.73
Mar 25	2.71
Mar 25	2.7
Mar 25	2.71
Feb 25	2.78
Feb 25	3.35
Feb 25	3.36
Feb 25	3.41
Jan 25	3.55
Jan 25	3.53
Jan 25	3.87
Jan 25	3.85
Jan 25	3.09
Dec 24	3.13
Dec 24	3.02
Dec 24	3.02
Dec 24	2.99
Nov 24	3.48
Nov 24	3.53
Nov 24	3.51
Nov 24	3.43
Nov 24	4.28
Oct 24	4.27
Oct 24	4.37
Oct 24	3.63
Oct 24	3.61
Sep 24	6.59
Sep 24	9.26
Sep 24	9.4
Sep 24	9.39
Aug 24	8.91
Aug 24	8.85
Aug 24	7.47
Aug 24	7.58
Aug 24	8.97
Jul 24	8.92
Jul 24	8.89
Jul 24	8.84
Jul 24	8.17
Jun 24	5.46
Jun 24	4.76
May 24	5.05
May 24	6
Apr 24	5.96
Apr 24	5.91
Mar 24	6.14
Mar 24	6.23
Feb 24	15.13
Jan 24	15.04

No video analysis for this stock yet. Request one from our team.

News: AVCTF

globenewswire.com · 8 Jul 2026

Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors

LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, is pleased to announce the appointment of Dr. Patrick Vink, a seasoned healthcare executive, to its Board of Directors as Non-Executive Deputy Chairman and Senior Independent Director. Dr. Vink serves as Chairman at Arch Biopartners Inc (TSXV:ARCH, OTCQB:ACHFF) and on the board of Spero Therapeutics Inc. (NASDAQ:SPRO) as Nominating and Corporate Governance Chair.

AI Analysis

Avacta Group Plc

Video analysis: AVCTF

News: AVCTF

Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors

Similar companies